![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Novel silica delivery system Nuvec (R) enters final pre-clinical development stage
N4 Pharma Plc (AIM: N4P), a specialist pharmaceutical company, has announced results fromthe company’s latest...
Sygnature Discovery moves US base to Kendall Square
Sygnature Discovery, the leading independent drug discovery and pre-clinical services company, has announced its US...
The rise and rise of Global Pharma Excipients Market
With the rise in the Global Pharma Industry, excipients too are bound to have their...
Sygnature Discovery develops AR molecular visualisation prototype
The space occupied by a drug molecule in three dimensions, and how it fits into...
Signant Health Brings Its eConsent Solution to China for Large Neuroscience Study in Collaboration...
Signant Health (formerly CRF Health and Bracket), a leading patient-centric technology company, has been selected...
Bora secures FDA approval for CDMO services
Bora, a contract development and manufacturing organization (CDMO) that specializes in modified release (MR) and...
Particle analysis: Growing demand with biologics
The development and introduction of new biological drug substances has been on the rise, and...
New calcium ingredient with improved flow and compactability properties
At this year’s CPhI Worldwide, mineral producer Omya will launch its new Calcipur® DC range,...
Cancer Research UK and Hummingbird Bioscience join forces to advance novel antibody drug into...
Cancer Research UK, the world’s leading cancer charity, and Hummingbird Bioscience, an innovative systems-biology enabled...
Vesselon Acquires FDA-Approved Lipid Microsphere Drug Imagent For Therapeutic Platform
Vesselon, an oncology therapeutics company, announced the acquisition of an FDA-approved drug Imagent®. Vesselon will...